Bruce F. Mackler

Bruce F. Mackler

President at Ethicann Pharmaceuticals, Inc.

81 year
Health Technology
Consumer Services
Finance

Profile

Bruce F.
Mackler
is currently a Director at Nielsen BioSciences, Inc., a Director & President-Regulatory Operations at Anew Biotechnology, Inc., and the President & Director at Ethicann Pharmaceuticals, Inc. He previously worked as a Director, VP-Regulatory Affairs & Development at Immunomic Therapeutics, Inc. from 2011 to 2013, an Independent Director at CanniMed Therapeutics, Inc. from 2016 to 2018, and as a Principal at Monumental Venture Partners LLC.
Mackler received his undergraduate degree from Temple University in 1964, his doctorate from Oregon Health & Science University in 1970, and his graduate degree from The Pennsylvania State University in 1965.
He also received a graduate degree from Houston College of Law in 1979.

Bruce F. Mackler active positions

CompaniesPositionStart
Director/Board Member -
President 2018-04-30
Director/Board Member -
All active positions of Bruce F. Mackler

Former positions of Bruce F. Mackler

CompaniesPositionEnd
CANNIMED THERAPEUTICS INC Director/Board Member 2018-03-14
Director/Board Member -
Corporate Officer/Principal -
See the detail of Bruce F. Mackler's experience

Training of Bruce F. Mackler

Houston College of Law Graduate Degree
The Pennsylvania State University Graduate Degree
Temple University (Pennsylvania) Undergraduate Degree
Oregon Health & Science University Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Bruce F. Mackler's experience

Connections

82

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies6

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

See company connections
  1. Stock Market
  2. Insiders
  3. Bruce F. Mackler